Survey: Over half of chronic liver disease patients had procedures cancelled or delayed due to COVID-19

The results of a new patient survey by the British Liver Trust reveal that over half of chronic liver disease patients say they’ve had procedures cancelled or delayed due to the COVID-19 pandemic. The findings reflect the worrying situation that many clinically extremely vulnerable patients find themselves in as we head into the winter months – a time when pressure […]

Read more

Heart attack: The four main ‘early signs’ that can indicate you’re having a heart attack

Heart attack: Experts claim a vegan diet can 'help prevent' them We use your sign-up to provide content in ways you’ve consented to and to improve our understanding of you. This may include adverts from us and 3rd parties based on our understanding. You can unsubscribe at any time. More info Heart attacks are serious medical emergencies that require immediate […]

Read more

Drug combination could make curative surgery possible for some liver cancer patients

A combination of the kinase-inhibitor drug cabozantinib and the immunotherapy drug nivolumab can make curative surgery possible in some liver cancer patients who would normally not be considered surgery candidates. Results published July 29 in the journal Nature Cancer by researchers at the Johns Hopkins Kimmel Cancer Center describe the benefits of this drug combination. Among 15 people with hepatocellular […]

Read more

The ethics of split liver transplantation: Analyzing case studies to make the right decision

Split liver transplantation (SLT) provides an opportunity to divide a donor liver and offer transplants to two small patients, one or both of whom could be a child. SLT, which is underused in the United States, could be used more widely to decrease the number of deaths of people on transplant waiting lists. In a new article, researchers address some […]

Read more

Researchers investigate link between the liver’s immune system composition and NASH pathology

Our livers work hard to perform an entire range of activities: helping us digest food, maintaining body temperature and serving as an important checkpoint of the immune system for everything that we eat. It is inside the liver that the unique, rich and complex network of immune cells and pathways is set up to decide what is a harmless food […]

Read more

A collaborative effort to evaluate treatment of liver and pancreatic tumors

HOUSTON, DENVER and CHICAGO ? The University of Texas MD Anderson Cancer Center and TriSalus Life Sciences today announced a strategic research collaboration to evaluate the treatment of tumors of the pancreas and liver by integrating interventional delivery of SD-101, an investigational toll-like receptor 9 (TLR9) agonist, in combination with checkpoint inhibition immunotherapy. Under the agreement, MD Anderson and TriSalus […]

Read more

Study offers localized treatment direction for a cause of Crohn's disease

People with Crohn's disease are typically treated with powerful anti-inflammatory medications that act throughout their body, not just in their digestive tract, creating the potential for unintended, and often serious, side effects. New research from the lab of Mark Sundrud, PhD, at Scripps Research, Florida suggests a more targeted treatment approach is possible. Crohn's disease develops from chronic inflammation in […]

Read more

A new technology to see tubes in 3-D in mice shows how the liver can recover in Alagille syndrome

Many diseases affect different vessels in our body, such as blood vessels, bile ducts or airways. Visualizing these in animal models of disease, to better understand what is actually going wrong form a structural point of view has been an area of intense research. We developed a new method, independent of antibodies or microscopes, to visualize multiple vessels at the […]

Read more

Algorithm Uses Routine Blood Tests to Detect Advanced Liver Disease

NEW YORK (Reuters Health) – It may be possible to pick up occult liver cirrhosis with an algorithm that uses data from routine blood tests, according to new research. The CIRRUS algorithm can find “a fingerprint for cirrhosis in the common blood tests done routinely by GPs,” Dr. Nick Sheron of the Foundation for Liver Research said in a news […]

Read more

Cytoglobin: Key player in preventing liver disease

Researchers have discovered that the use of Cytoglobin (CYGB) as an intravenous drug could delay liver fibrosis progression in mice. CYGB, discovered in 2001 by Professor Norifumi Kawada, is present in hepatic stellate cells, the cells that produce fibrotic molecules such as collagens when the liver has acute or chronic inflammation induced by different etiologies. The enhancement of CYGB on […]

Read more
1 2 3 7